The XanaCIDD depression trial has received approval to proceed with the trial in the UK without alterations.
Also positive news from the Safety Review Committee recommending the trial continue without alteration.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.7¢ | $76.07K | 2.734M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 725877 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 535081 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| ACW (ASX) Chart |